ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis
14:22 (27/01/12)Fuente: eleconomista.es Servicios Premium Ecotrader El Superlunes Servicios gratuitos Listas y rankings Club elEconomista. es Cartera ForosServicios Premium Ecotrader El Superlunes Servicios gratuitos Listas y rankings Club elEconomista. According to the National Multiple Sclerosis Society, approximately half of all people initially...Búsquedas relacionadas con Maimonides Medical Center Scientific Director | Imperial College | Severity Score | Walking Scale | European Union | United States | Cellular Neuroscience | New York | Biogen Idec | Cartera Foros |